Resource Centre
Video )
How to sequence full-length 16S and ITS amplicons
Video Webinar: Microbes in microgravity: identifying diversity and adaptions
Workflow )
Workflow overview: microbial amplicon barcoding
Workflow )
Workflow overview: 16S sequencing
Publication )
Evaluating the diagnostic utility of 16S ONT sequencing in patients with central nervous system infections and its usefulness in antimicrobial
Publication )
Microbial interactions induce the mutational signature of mismatch repair deficiency in colorectal cancer and associated with EPPK1 mutations
Publication )
Nationwide multicentre study of nanopore long-read sequencing for 16S rRNA-species identification
Brochure )
Brochure: EPI2ME — data analysis for all levels of expertise
Video )
Portable 16S rRNA sequencing for antimicrobial stewardship
Publication )
A high-throughput and time-efficient nanopore full-length 16S rRNA gene sequencing protocol for synthetic microbial communities
Brochure )
Brochure: microbiology and infectious disease research
Getting started guide Getting started guide: microbial sequencing
Publication )
A multiplex amplicon nanopore sequencing assay for simultaneous characterisation of UK tick species, their microbiomes, and their bloodmeal origin
Publication )
Human milk microbiota across lactation stages and free glutamate concentrations in healthy Ecuadorian women
Publication )
Long-read 16S rRNA amplicon sequencing reveals microbial characteristics in patients with colorectal adenomas and carcinoma lesions in Egypt
Publication )
Clinical performance of real-time nanopore metagenomic sequencing for rapid identification of bacterial pathogens in cerebrospinal fluid
Publication )
Gene expression profiles reveal distinct mechanisms driving chronic obstructive pulmonary disease exacerbations
Publication Saliva microbiome profiling by full-gene 16S rRNA Oxford Nanopore Technology versus Illumina MiSeq sequencing
Publication )
Moving beyond Oxford Nanopore standard procedures: new insights from water and multiple fish microbiomes
Publication )
Gut microbiome dysbiosis and immune activation correlate with somatic and neuropsychiatric symptoms in COVID-19 patients
